Ellsworth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.02M Buy
74,759
+9,139
+14% +$737K 0.99% 42
2026
Q1
$5.69M Buy
65,620
+3,612
+6% +$346K 1.07% 41
2025
Q4
$6.14M Buy
62,008
+3,350
+6% +$325K 1.21% 32
2025
Q3
$5.59M Sell
58,658
-3,383
-5% -$311K 1.19% 33
2025
Q2
$5.41M Buy
62,041
+2,088
+3% +$177K 1.32% 31
2025
Q1
$5.39M Buy
+59,953
New +$5.36M 1.41% 22
2020
Q3
Sell
-13,712
Closed -$1.26M 89
2020
Q2
$1.26M Buy
+13,712
New +$1.31M 1.38% 31

Other funds holding MDT

Ellsworth Advisors's MDT Position: Q2 2026 in Review

Ellsworth Advisors increased its Medtronic (MDT) stake by 14% in Q2 2026, buying an estimated $737K and bringing the position to 74,759 shares worth $6.02M. The position accounts for 0.99% of the portfolio, ranked #42.

Ellsworth Advisors first reported a position in MDT in Q2 2020 and has held it in 7 quarters since. The position peaked at $6.14M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ellsworth Advisors held 74,759 shares of Medtronic worth $6.02M as of Q2 2026.
  • Ellsworth Advisors bought 9,139 Medtronic shares in Q2 2026, an estimated $737K.
  • Medtronic made up 0.99% of Ellsworth Advisors's portfolio in Q2 2026, its #42 holding.
  • Ellsworth Advisors first reported a position in Medtronic in Q2 2020 and has held it in 7 quarters since.
  • Ellsworth Advisors's Medtronic position peaked at $6.14M in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.